Join
Live feed
·
INSIDERFilingvia Quantisnow
Axsome Therapeutics Inc. logo

Director Coleman Mark sold $783,375 worth of shares (7,500 units at $104.45), decreasing direct ownership by 14% to 46,637 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AXSM· Axsome Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AXSM (Axsome Therapeutics Inc.) and more on Quantisnow.